S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.16%) $0.928
USD/NOK
(0.20%) $10.86
USD/GBP
(0.02%) $0.792
USD/RUB
(-0.46%) $92.15

Realtime updates for Acurx Pharmaceuticals, [ACXP]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 16:00

5.15% $ 2.45

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 16:00):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections...

Stats
Today's Volume 84 565.00
Average Volume 179 503
Market Cap 35.45M
EPS $-0.380 ( 2024-03-18 )
Next earnings date ( $-0.240 ) 2024-05-10
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -2.13
ATR14 $0.0200 (0.81%)
Insider Trading
Date Person Action Amount type
2024-01-19 Sailer Carl Buy 19 737 Common Stock
2024-01-19 Sailer Carl Sell 19 737 Warrants for Common Stock
2021-12-02 Deluccia Robert J Sell 40 000 Common Stock
2023-12-12 Deluccia Robert J Sell 40 000 Common Stock
2024-01-03 Deluccia Robert J Buy 19 737 Common Stock
INSIDER POWER
38.32
Last 58 transactions
Buy: 2 790 791 | Sell: 229 212

Volume Correlation

Long: 0.19 (neutral)
Short: 0.54 (weak)
Signal:(63.924) Neutral

Acurx Pharmaceuticals, Correlation

10 Most Positive Correlations
SISI0.968
GLMD0.965
PEAR0.963
GMBL0.962
PPBT0.951
LAWS0.948
ACET0.945
PTE0.944
NCBS0.944
CYTO0.942
10 Most Negative Correlations
GXII-0.969
CLBT-0.961
GASS-0.958
ISEE-0.958
RAM-0.957
MITA-0.957
NECB-0.956
IVCB-0.955
AGGR-0.955
CSWC-0.954

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Acurx Pharmaceuticals, Correlation - Currency/Commodity

The country flag 0.81
( strong )
The country flag 0.75
( moderate )
The country flag 0.00
( neutral )
The country flag 0.68
( moderate )
The country flag -0.15
( neutral )
The country flag -0.70
( moderate negative )

Acurx Pharmaceuticals, Financials

Annual 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-1.150
Q4 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.380
Q3 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.240
Q2 2023
Revenue: $0
Gross Profit: $0 (0.00 %)
EPS: $-0.280

Financial Reports:

No articles found.

Acurx Pharmaceuticals,

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators